Dr. Luke E. Sewall, MD

Dr. Sewall practices at Vascular and Interventional Professionals in Hinsdale, Illinois.

Dr. Sewall's NPI, 1487672747, was assigned on July 17, 2006. Dr. Sewall graduated from Johns Hopkins University School of Medicine in 1988. Dr. Sewall holds Illinois license 036099347.

Dr. Sewall's primary practice is Vascular and Interventional Professionals, at 911 N Elm St, Hinsdale, IL 60521 in Dupage County. The practice phone is (630) 856-7460.

Dr. Sewall's primary practice is Vascular and Interventional Professionals in Hinsdale, Illinois. Dr. Sewall is also affiliated with UChicago Medicine AdventHealth Hinsdale. The medical group on file is Vascular and Interventional Professionals. Dmand AI also links Dr. Sewall to 4 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sewall practices, 9 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Sewall's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Sewall is licensed in Illinois.

CMS data shows 1,961 Medicare services from Dr. Sewall across 17 procedure codes in 2024, for 370 Medicare patients. Medicare paid $159,957 for them.

CMS counts 370 Medicare patients who saw Dr. Sewall in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sewall's median patient age at 71, with 36% women.

In 2024, Dr. Sewall wrote 155 Medicare Part D claims for 66 patients. 94% of them were for generic drugs. CMS names the drug for 126 of them, across 5 drugs with 11 or more claims each, at $771 in total drug cost. In 2023, CMS named 23 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Sewall for performance year 2024, reported individually. Dr. Sewall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of leg revascularization (restoring blood flow) by Dr. Sewall, more than 66% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Sewall, published from 2016 to 2023. The most frequent topics are Chronic Pain, Pelvic Pain and Phlebography. Dr. Sewall has published most often in J Vasc Interv Radiol. Dr. Sewall's most frequent co-authors are Michael James Sichlau, MD, Brenda N. Chen, PA-C and Peter Rowe, MD.

Dmand AI links Dr. Sewall to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Postthrombotic Syndrome and Venous Insufficiency.

CMS Open Payments shows 279 general payments to Dr. Sewall from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 33% of the total. BTG International, Inc. paid the most, $11,849. It also lists 3 research payments totaling $995 in 2020.

Dr. Sewall graduated from Johns Hopkins University School of Medicine in 1988.